PROM1 and cancer: Recurrent ovarian tumors are enriched with cancer stem cell-like cells and stem cell mediators, such as CD44, CD133, NOTCH, Wnt, TGFbeta, ALDH1, thus supporting the hypothesis that cancer stem cells contribute to the disease recurrence [192].